Select region
Submit
All products

Flixene Vascular Grafts

ePTFE Vascular Grafts

Flixene provides a durable vascular access option.

Questions? Contact us.
Durable vascular access with Flixene vascular grafts.
Flixene vascular graft is designed to deliever premium performance for dialysis access.

Flixene for dialysis access

The Flexine graft has been demonstrated in clinical literature to be a reliable AV access conduit for dialysis care in terms of successful cannulation and patency. 

It incorporates a 3 layer ePTFE design for use in both vascular bypass and AV Access graft applications. The 3 layer construction provides Flixene significantly improved strength over previous Getinge double layer ePTFE grafts. To address a broad number of patient needs, Flixene grafts are offered in a variety of configurations including:

A choice of configurations

Straight:

Getinge offers an extensive line of straight grafts.  Straight grafts are often used for those applications where a bypass is needed and vessel diameter remains a constant from the proximal to the distal anastomosis. This configuration is offered in both graduated wall and standard wall thickness.

Tapered:

A wide selection of tapered grafts is also offered for those clinical applications where flow dynamics need to be altered or when performing a bypass between two different diameter vessels. [1] Configuration available in both graduated wall and standard wall thickness.

Graduated Wall (GW):

Designed to be thinner at the ends of the graft compared to the standard wall design. The Flixene GW grafts offer a reduced wall thickness at the proximal and distal 8 cm segments of the graft. Getinge's engineers were able to achieve this while ensuring sufficient strength to withstand needle cannulation. [1]

Standard Wall (SW):

Getinge also offers a full line of standard wall thickness grafts.

Flixene is engineered to meet the clinical demands for dialysis access. [1]

Clinical data demonstrates the ability of Flixene to be safely cannulated within 24 to 72 hours, enabling patients to begin dialysis within days rather than weeks. [2]

Flixene comes equipped with the SLIDER GDS tunneling system. Use of the SLIDER GDS has the potential for reducing trauma, tunnel bleeding, graft sweating, edema, and operative infections. [3]

Flixene has an average outer surface porosity of 60µm, and an average inner surface porosity of 20µm. [1] 

  • Flixene AV access graft brochure

    Learn more about the Flixene AV access graft. Flixene includes a slider GDS system with plastic sheath to facilitate tunneling, minimizes pre-wetting and contamination of the graft. Flixene is shown to be a viable option for early cannulation within 3 days, reducing the need and risks associated with CVCs for patients.

Visit our Academy – training and education designed to enhance your proficiency

For more information about our onsite events or remote trainings, you can also contact your local sales & service representative.

Explore training content for Flixene Vascular Grafts

  1. 1. Data on file

  2. 2. Schild AF, Schuman ES, Noicely K, et al. Early cannulation prosthetic graft (Flixene) for arteriovenous access. J Vasc Access. 2011 Jul-Sep;12(3):248-52.

  3. 3. Schild AF, Baltodano NM, Alfieri K, Livingstone J, Raines JK. New Graft for Low Friction Tunneling in Vascular Access Surgery. J Vasc Access. 2004 Jan-Mar;5(1):19-24.

You are now leaving Getinge.com. You might access content  not managed by Getinge team, in that case Getinge can not be hold responsible of the content. 

I understand! Stay in Getinge.com

Dear user, you have clicked a link and will now see International fallback content.
Getinge ANZ does not review or control this content. It is possible that some of the products on Getinge International are not approved in your country. For more specific Australian information please contact us 

OK!

Dear user, You now see International fallback content. Getinge ANZ does not review or control this content. It is possible that some of the products on Getinge international are not approved in your country. For more specific  information relevant for your region please contact us.